aldosterone has been researched along with cyclic adp-ribose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, Y; Mabuchi, H; Oda, N; Takeda, Y; Usukura, M; Yoneda, T | 1 |
| Cao, H; Fu, L; Huang, F; Li, A; Li, S; Liao, C; Wang, X; Yuan, Y; Zeng, W; Zhang, B; Zhao, L | 1 |
2 other study(ies) available for aldosterone and cyclic adp-ribose
| Article | Year |
|---|---|
The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas.
Topics: Adenoma; ADP-ribosyl Cyclase; Adrenal Cortex Neoplasms; Aldosterone; Angiotensins; Case-Control Studies; Cyclic ADP-Ribose; Cytochrome P-450 CYP11B2; Dose-Response Relationship, Drug; Gene Expression; Humans; Imidazoles; In Vitro Techniques; Losartan; Pyridines; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 2005 |
BST-1 aggravates aldosterone-induced cardiac hypertrophy via the Ca2+ /CaN/NFATc3 pathway.
Topics: ADP-ribosyl Cyclase 1; Aldosterone; Animals; Calcium; Cardiomegaly; Cyclic ADP-Ribose; NFATC Transcription Factors; Rats | 2023 |